First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- 1200 Pharma, LLC
- Links
- Sign up for this study
- ID
- NCT04761601
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 106 study participants
- Last Updated